Data / Form D filings / Macrotope, Inc.
Macrotope, Inc.: Form D filings
Macrotope, Inc., a pharmaceuticals company in Princeton, NJ, filed 3 Form D notices with the SEC between 2022 and 2025. The latest, on May 30, 2025, reports $400,000 sold of a $1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 158 SPRINGDALE ROAD, Princeton, NJ, 08540
- Phone
- (609) 915-4246
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1913044
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | New notice | $1,000,000 | $400,000 | $600,000 | 1 | May 27, 2025 | sec.gov |
| Aug 18, 2023 | New notice | $750,000 | $300,000 | $450,000 | 1 | Aug 14, 2023 | sec.gov |
| Jun 3, 2022 | New notice | $750,000 | $200,000 | $550,000 | 1 | May 20, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Elliot Camptbell | Executive Officer, Director | |
| Stephen Anderson | Executive Officer, Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of May 26, 2025 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Macrotope, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.